I want to do a proper deep-dive on TB-500 (Thymosin Beta-4 fragment) because I see a lot of confusion in peptide communities about what this compound actually does, what the evidence supports, and where the hype outpaces the science.
Background: Thymosin Beta-4 (TB4) is a naturally occurring 43-amino acid peptide that plays a central role in actin sequestration and cytoskeletal dynamics. TB-500 is a synthetic fragment corresponding to the active region of TB4. It's been researched primarily for wound healing, tissue repair, and anti-inflammatory properties.
Key published research:
- Sosne et al. (2007) — demonstrated corneal wound healing in animal models (PMID: 17667962)
- Malinda et al. (1999) — showed promotion of dermal wound healing, angiogenesis, and hair growth in rats (PMID: 10531521)
- Bock-Marquette et al. (2004) — cardioprotective effects post-MI in mice, published in Nature (PMID: 15340094)
- Smart et al. (2011) — activation of epicardial progenitor cells (PMID: 21346761)
The cardioprotective data is actually quite compelling. Thoughts on the current state of the evidence?
Excellent overview. TB4 is one of the more interesting peptides in the repair/regeneration space precisely because it has a clear molecular mechanism — it's not just "thrown at a wall to see what sticks."
The actin-binding activity is key. By sequestering G-actin monomers, TB4 promotes cell migration (particularly endothelial cells and keratinocytes) to wound sites. This isn't some vague "growth factor signaling" story — it's a direct biophysical effect on cytoskeletal remodeling.
What's often overlooked is the anti-inflammatory component. TB4 downregulates NF-κB signaling and reduces pro-inflammatory cytokines (IL-1β, TNF-α) in multiple models. The Sosne group published work on this in the context of corneal inflammation (PMID: 20926833). This dual action — promoting repair while dampening inflammation — is why TB-500 has attracted attention for tendon/ligament injuries where chronic inflammation impedes healing.
The cardioprotective data is actually quite compelling.
Agreed, but let's be careful here. The Bock-Marquette Nature paper showed that TB4 could reduce infarct size and improve cardiac function when administered before or immediately after ischemic injury in mice. That's a very specific experimental paradigm. Extrapolating this to "TB-500 is good for your heart" is a stretch that the data doesn't support.
Can we talk practical application? I've got a chronic Achilles tendinopathy that's been resistant to physio, eccentric loading protocol, and even a PRP injection. Three different PTs and an ortho have all said "keep doing the eccentrics and be patient" but it's been 14 months.
Is there reasonable evidence to try TB-500 for this? And what protocol would you suggest?
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsThis is probably the most common use case for TB-500 in the peptide community, and honestly it's one where I think the risk-benefit is favorable given the limited options for chronic tendinopathy.
There isn't a direct RCT for TB-500 in human tendinopathy — let me be upfront about that. But there's animal data showing TB4 promotes tendon healing. Xu et al. (2013, PMID: 24069069) showed improved histological and biomechanical outcomes in a rat Achilles tendon transection model with local TB4 injection.
Common protocol that I've seen used and used myself:
- Loading phase (weeks 1-4): 2.5 mg TB-500 subcutaneously, twice per week (total 5 mg/week)
- Maintenance phase (weeks 5-8): 2.5 mg once per week
- Injection site: abdominal subQ, not local to the injury (it's systemically active)
- Continue physical therapy / eccentric loading protocol throughout
I ran this exact protocol for a proximal hamstring tendinopathy that had persisted for 10 months. By week 6, I was able to return to running without pain. Was it the TB-500, was it just time, was it the continued PT? Impossible to say definitively. But the timeline of improvement correlated with the cycle.
Some practical notes on TB-500:
Reconstitution and dosing: TB-500 typically comes in 5 mg vials. Reconstitute with 1 mL bacteriostatic water for a 5 mg/mL solution. For a 2.5 mg dose, draw 0.5 mL. It's a pretty forgiving peptide in terms of stability — more robust than many other research peptides.
Molecular weight: 4963 Da (full-length TB4 is ~4921 Da). Check the CoA — legitimate TB-500 should have HPLC purity ≥ 97% and mass spec confirmation.
Storage: Lyophilized powder is stable at room temp for months but refrigeration extends shelf life. Once reconstituted, keep refrigerated and use within 4-6 weeks. Don't freeze reconstituted solution.
Cost: Runs about $30-50 per 5 mg vial, so a full loading + maintenance cycle is roughly $200-350 depending on source.